Q3
Predicted--
Actual$0.10
ABBV
$224.46
$0.46
( 0.20% )
Today
$226.54
$224.91
$223.28
Earnings
Q2
Predicted--
Actual$0.52
Q1
Predicted--
Actual$0.72
Q4
Predicted--
Actual$-0.02
ABBV Key Statistics
Market Cap
402B
High Today
$229.25
Low Today
$223.06
Volume
4.72M
Open Price
$228.97
52 Week High
$237.97
52 Week Low
$204.27
Average Volume
71.8M
About ABBV
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Employees
55,000
Headquarters
NORTH CHICAGO, IL